J M WILSON - JoVE Visualize

Showing results (501-510 of 535) with videos related to

Pageof 54

Sort By:

Gene Therapy|February 18, 2011

Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9A Van der Perren, J Toelen, M Carlon, et al.

Human Molecular Genetics|May 25, 2026

Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuriaDominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.

Human Gene Therapy|December 1, 1996

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2001

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectorsM A Schnell, Y Zhang, J Tazelaar, et al.

Journal of Thrombosis and Haemostasis : JTH|September 28, 2006

Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyT Vandendriessche, L Thorrez, A Acosta-Sanchez, et al.

Human Gene Therapy|February 27, 1999

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.

Human Gene Therapy|June 2, 1998

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.

Human Gene Therapy|October 6, 1998

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.

Journal of Inherited Metabolic Disease|September 11, 2019

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuriaJuliette H Hughes, Peter J M Wilson, Hazel Sutherland, et al.

Cancer Gene Therapy|July 1, 1997

The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.

Pageof 54

Showing results (501-510 of 535) with videos related to

Sort By:

Pageof 54

Gene Therapy|February 18, 2011

Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9A Van der Perren, J Toelen, M Carlon, et al.

Human Molecular Genetics|May 25, 2026

Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuriaDominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.

Human Gene Therapy|December 1, 1996

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2001

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectorsM A Schnell, Y Zhang, J Tazelaar, et al.

Journal of Thrombosis and Haemostasis : JTH|September 28, 2006

Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyT Vandendriessche, L Thorrez, A Acosta-Sanchez, et al.

Human Gene Therapy|February 27, 1999

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.

Human Gene Therapy|June 2, 1998

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.

Human Gene Therapy|October 6, 1998

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.

Journal of Inherited Metabolic Disease|September 11, 2019

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuriaJuliette H Hughes, Peter J M Wilson, Hazel Sutherland, et al.

Cancer Gene Therapy|July 1, 1997

The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.

Pageof 54